Sophie Postel-Vinay reported that PARP inhibition enhanced the intrinsic immunity of tumor cells in NSCLC with deficiency in excision repair cross-complementing group 1, a gene which has crucial role in the nucleotide excision repair [34]. This evidence concerns the gene PARP1 and non-small cell lung carcinoma.